Clinical Trials Sponsored by CH Agen

Total 1528 results

University Hospital, Clermont-Ferrand
Jacques Lacarin Hospital Center; CH Issoire; CH Montluçon; CH Aurillac; CH Moulins; CH Thiers and other collaborators

Completed

Measuring the Impact of the French Version of the Whiplash Book (WHIPLASH)

Whiplash Trauma

France
University Hospital, Caen
CH Lisieux; CH Avranches

Unknown

Incidence of Post Cystography Urinary Tract Infections in the Pediatric Population (IUCPED)

Urinary Infection

France
Therenva
CH Libourne

Completed

Comparison of Lower Limb Endovascular Interventions With and Without the EndoNaut Workstation (COMPAR-MI)

Peripheral Arterial Disease

France
University Hospital, Clermont-Ferrand
Université d'Auvergne; Jacques Lacarin Hospital Center; CRRF La Châtaigneraie; CH... and other collaborators

Unknown

Secondary Postpartum Hemorrhage (SPPH)

Postpartum Hemorrhage | Maternal Morbidity | Delivery | Postpartum Endometritis | Retained Placenta

France
Ch Mont de Marsan

Completed

Follow-up of Osteo-articular Biomarkers After Spa Therapy in a Population With Knee Osteoarthritis and Their Correlation With the Clinical Evolution (BIOMARTHROSE)

Knee Osteoarthritis

France
Ch Mont de Marsan

Completed

Assessment of Fears of Patients Standing at the Operating Block

Anxiety and Fear

France
Ch Mont de Marsan

Withdrawn

Observational Study of the Evaluation of Post Traumatic Stress Post Stroke (SPTD)

Post Traumatic Stress Disorder

France
University Hospital, Clermont-Ferrand
Hospices Civils de Lyon; University Hospital, Grenoble; Hôpital de la Croix-Rousse and other collaborators

Recruiting

Protocol of Diuretics Use in Congestive Therapy in Heart Failure (ProDUCT-HF)

Heart Failure | Chronic Heart Failure | Acute Heart Failure

France
Centre Hospitalier Universitaire, Amiens
CH Montdidier

Recruiting

Intestinal Microbiota Profiling in Severe Acute Alcoholic Hepatitis Patients (HepatAlc-IM)

Corticosteroids | Intestinal Microbiota | Alcohol | Severe Acute Alcoholic Hepatitis

France
Centre Hospitalier Universitaire, Amiens
Centre Hospitalier de Beauvais; University Hospital, Montpellier; University... and other collaborators

Recruiting

Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility (HyperBetashock)

Septic Shock | Tachycardia | Mortality During Septic Shock | Beta-blocker

France
University Hospital, Geneva
Centre Valaisan de Pneumologie, CH-3960Montana

Completed

Bronchoscopy and Bispectral Index (BIS) - Guided Sedation

Bronchoscopy

Switzerland
University Hospital, Montpellier
CHU de la Timone, Marseille, France; CHU Carémeau, Nîmes, France; CHU de Bordeaux... and other collaborators

Recruiting

Biomarkers in Polyradiculoneuropathies (BIP)

Guillain-Barre Syndrome | CIDP

France
Agen Biomedical

Completed

Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis

Deep Vein Thrombosis

United States, Canada
Agen Biomedical

Completed

A Phase II Study to Evaluate the Efficacy of ThromboView® in the Detection of Pulmonary Emboli

Acute Pulmonary Embolism

United States, Canada
Centre Hospitalier Universitaire de Nīmes
University Hospital, Montpellier; Hospital Center, Alès; CH Bagnols sur Cèze; CH... and other collaborators

Recruiting

Feasability of a Care Pathway Integrating Collaborative Tele-expertise to Prevent Recurring Hospitalisations for Diabetic Patients (TELXCODIA)

Diabetes Mellitus

France
Yale University
Heffter Research Institute; Ceruvia Lifesciences; CH TAC LLC

Completed

Psilocybin for the Treatment of Cluster Headache

Cluster Headache

United States
University Hospital, Clermont-Ferrand
Jacques Lacarin Hospital Center; CH Montluçon

Unknown

Exploration of the Reward System by Functional MRI in Narco-cataplexy Patients With and Without REM Sleep Behavior Disorder (NC-TCSP-IRMf)

Narcolepsy | Cataplexy

France
Novartis
World Health Organization; Avenue Appia 20; CH - 1211 Geneva 27; Switzerland

Completed

Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria

Plasmodium Falciparum Malaria

Kenya, Nigeria, Tanzania
University Hospital, Basel, Switzerland
SenTec AG, Ringstrasse 39, CH-4106 Therwil

Terminated

Accuracy of Non-invasive Continuous CO2-Monitoring

Blood Gas Monitoring, Transcutaneous

Switzerland
University Hospital, Basel, Switzerland
Toppharm Apotheke Hersberger, Spalenberg 41, CH-4051 Basel

Recruiting

Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure

Adverse Drug Reaction | Therapy Failure

Switzerland
University Hospital, Basel, Switzerland
Dr Josef Vavrina, HNO Seepraxen, CH-8810 Horgen, Zurich

Completed

Nasal Septum Perforation Treatment Using Tissue Engineered Cartilage Graft (NSP)

Nasal Cartilage Septum Perforations

Switzerland
University Hospital, Clermont-Ferrand
Hospices Civils de Lyon; Saint Antoine University Hospital; Centre Hospitalier... and other collaborators

Completed

Regional Anaesthesia in Intensive Care Unit (Week'ALR)

Intensive Care Unit

France
Amgen

Not yet recruiting

Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV

Vasculitis
Amgen

Recruiting

A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe AD (ROCKET-Outpost)

Atopic Dermatitis

United States
Amgen

Recruiting

A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.

Postmenopausal Osteoporosis

India
Amgen

Recruiting

A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

Melanoma

Italy, Spain, Czechia, Estonia, Bosnia and Herzegovina, Portugal, Romania, Georgia, Lithuania, Malaysia, United States, France, Canada, Thailand, Croatia, Mexico, Serbia
Amgen

Recruiting

Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

United States
Amgen

Recruiting

Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer (FORTITUDE-102)

Gastric Cancer | Gastroesophageal Junction Adenocarcinoma

Korea, Republic of, United States, Israel, Italy, Spain, Australia, Germany, United Kingdom, Austria, France, Japan, Switzerland, Taiwan, Belgium, Poland, China, Thailand, Canada, Czechia, Singapore, Hungary, Argentina, Brazil, Portugal, Roman... and more
Amgen

Recruiting

Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis

United States, Taiwan, Switzerland, Germany, Spain, Turkey, Greece, Japan, Denmark, Korea, Republic of, Austria, Italy, Netherlands, Poland, Romania, Belgium, Argentina, Bulgaria, Czechia, Finland, Hungary, Mexico, Latvia, France, Canada, Slovaki...
Amgen

Recruiting

Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone

Giant Cell Tumor of Bone

Taiwan, China
Amgen

Recruiting

Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease (BEAN)

Behçet Disease

Spain, United Kingdom, Turkey, France, Greece, Italy, Israel, Switzerland
Amgen

Recruiting

A Study of Subcutaneous Blinatumomab Administration in Acute Lymphoblastic Leukemia (ALL) Patients

B Cell Precursor Acute Lymphoblastic Leukemia

Japan, Australia, Spain, United States, Italy, Germany, France, Turkey, Canada, Netherlands, Austria
Amgen

Recruiting

Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)

B-precursor Acute Lymphoblastic Leukemia

United States
Amgen

Recruiting

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Advanced Solid Tumors | Kirsten Rat Sarcoma (KRAS) pG12C Mutation

United States, Italy, Taiwan, Spain, United Kingdom, Australia, Austria, Germany, Belgium, Japan, Netherlands, Korea, Republic of, Canada
Amgen

Recruiting

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

Chemotherapy-induced Thrombocytopenia

United States, Spain, Turkey, Argentina, Greece, Austria, Brazil, Bulgaria, Chile, Colombia, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Ukraine, Hungary
Amgen

Recruiting

Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection

Melanoma | Herpetic Infection

United Kingdom, Austria, United States, Israel, Switzerland
Amgen

Completed

Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta

Osteogenesis Imperfecta

Spain, United States, Turkey, Austria, Germany, Greece, Hungary, Italy
Amgen

Active, not recruiting

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial

Atherosclerotic Cardiovascular Disease

United States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Italy, Portugal, Greece, Hong Kong, Hungary, United Kingdom, France, Bulgaria, Germany, Finland, Japan, Sweden, Canada, Denmark, Icelan... and more
Amgen

Completed

Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants

Inflammatory Diseases

United Kingdom
Amgen

Terminated

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 562 in Subjects With r/r Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, or Follicular Lymphoma

Mantle Cell Lymphoma (MCL) | Follicular Lymphoma (FL) | Diffuse Large B-cell Lymphoma(DLBCL)

United States, Canada, Germany, Belgium
Amgen

Active, not recruiting

Myasthenia Gravis Inebilizumab Trial (MINT)

Myasthenia Gravis

United States, Argentina, Belarus, Brazil, Canada, China, Denmark, France, Germany, India, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
Amgen

Completed

An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis (DISCREET)

Psoriasis

United States, Belgium, Italy, France, Germany, Puerto Rico, Canada
Amgen

Completed

A Study to Describe the Characteristics of Patients Treated With Apremilast for Plaque Psoriasis in Italian Routine Clinical Practice (DARWIN)

Plaque Psoriasis

Italy
Amgen

Completed

Study of VIB7734 for the Treatment of Moderate to Severely Active SLE (RECAST SLE)

Lupus Erythematosus, Systemic

United States, Spain, Serbia, Mexico, Poland, Greece, Argentina, India, Russian Federation, Taiwan, Ukraine
Amgen

Completed

Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata

Alopecia Areata

United States, Canada
Amgen

Active, not recruiting

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

Relapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid Leukemia

United States, Australia, Japan, Germany, Canada
Amgen

Active, not recruiting

A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)

KRAS p.G12C Mutant Advanced Solid Tumors

United States, France, Canada, Spain, Belgium, Korea, Republic of, Austria, Australia, Hungary, Greece, Germany, Japan, Romania, Switzerland, Brazil, Portugal
Amgen

Completed

A Controlled Trial of Erenumab in Migraine Prevention

Migraine

Japan
Amgen

Active, not recruiting

Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke (VESALIUS-CV)

Coronary Heart Disease (CHD)

Canada, France, United States, Spain, United Kingdom, Korea, Republic of, Netherlands, Austria, Australia, Czechia, Taiwan, Finland, Hungary, Italy, Poland, Greece, Germany, Brazil, Latvia, Denmark, Mexico, Russian Federation, Bulgaria and more
Amgen

Completed

AMG 404 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Canada, United States, Belgium, Spain, Brazil, Korea, Republic of, Poland, Singapore, Taiwan, Japan, United Kingdom, Australia, Turkey

Clinical Trials Sponsored by CH Agen

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations